Management of lower urinary tract symptoms in men: Summary of NICE guidance

BMJ (Online)

Volumn 340, Issue 7759, 2010, Pages 1300-1301

  Jones, Clare ^a   Hill, Jennifer ^a   Chapple, Christopher ^a,b  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PLANT EXTRACT; PUMPKIN SEED EXTRACT; SABAL EXTRACT; TAMSULOSIN; TERAZOSIN; UNCLASSIFIED DRUG;

BLADDER DYSFUNCTION; COST EFFECTIVENESS ANALYSIS; EXPERIENCE; GROUPS BY AGE; HUMAN; LOWER URINARY TRACT SYMPTOM; MICTURITION; NATIONAL HEALTH ORGANIZATION; NOCTURIA; OVERACTIVE BLADDER; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSTATE DISEASE; SHORT SURVEY; SPHINCTER; TRAINING; URETHRA DISEASE; URINARY FREQUENCY; URINARY HESITANCY; URINARY URGENCY; URINE INCONTINENCE;

ADRENERGIC ALPHA-ANTAGONISTS; CHOLINERGIC ANTAGONISTS; HUMANS; MALE; MEDICAL HISTORY TAKING; PATIENT EDUCATION AS TOPIC; PHYSICAL EXAMINATION; PRACTICE GUIDELINES AS TOPIC; PROSTATISM; REFERRAL AND CONSULTATION;

EID: 77953689712     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c2354     Document Type: Short Survey

References (7)

1. Chapple CR. BPH disease management. Introduction and concluding remarks. Eur Urol 1999;36(suppl 3):1-6.[Web of Science][Medline]
2. National Institute for Health and Clinical Excellence. The management of lower urinary tract symptoms in men. (Clinical guideline 97.) 2010. www.nice.org.uk/CG97
3. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.[CrossRef][Web of Science][Medline]
4. Chapple CR, MacDiarmid SA, Patel A. Urodynamics made easy. 3rd ed. Churchill Livingstone, 2009.
5. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57.[Web of Science][Medline]
6. Mebust WK, Roizo R, Schroeder F, Villers A. Correlations between pathology, clinical symptoms and the course of the disease. International Consultation on Benign Prostatic Hyperplasia Proceedings 1991:51-62.
7. National Institute for Health and Clinical Excellence. Urinary incontinence: the management of urinary incontinence in women. (Clinical guidance 40.) 2006. www nice org uk/CG40.